tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

EGRX Stock Latest News

Eagle Pharmaceuticals says unlikely to file Form 10-Q or 10-K by May 13
The FlyEagle Pharmaceuticals says unlikely to file Form 10-Q or 10-K by May 13
4d ago
EGRX
Eagle Pharmaceuticals to present data from Phase III trial of amisulpride
PremiumThe Fly
Eagle Pharmaceuticals to present data from Phase III trial of amisulpride
4d ago
EGRX
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida
PremiumPress Releases
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida
4d ago
EGRX
Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays
PremiumCompany Announcements
Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays
7d ago
8K
EGRX
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
PremiumPress Releases
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
7d ago
EGRX
Eagle Pharmaceuticals discloses resignation of CFO Brian Cahill
PremiumThe FlyEagle Pharmaceuticals discloses resignation of CFO Brian Cahill
1M ago
EGRX
Eagle Pharmaceuticals Announces CFO Transition and Leadership Changes
PremiumCompany Announcements
Eagle Pharmaceuticals Announces CFO Transition and Leadership Changes
1M ago
8K
EGRX
Eagle Pharmaceuticals Faces Nasdaq Delisting Deadline
PremiumCompany Announcements
Eagle Pharmaceuticals Faces Nasdaq Delisting Deadline
2M ago
8K
EGRX
Eagle Pharmaceuticals Updates Bendamustine IP Portfolio
PremiumMarket News
Eagle Pharmaceuticals Updates Bendamustine IP Portfolio
3M ago
8K
EGRX
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
PremiumPress Releases
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
3M ago
EGRX
Eagle provides update on bendamustine intellectual property portfolio
PremiumThe Fly
Eagle provides update on bendamustine intellectual property portfolio
3M ago
EGRX
SHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors
PremiumClass Action
SHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors
4M ago
EGRX
SHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
PremiumClass ActionSHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
4M ago
EGRX
Eagle Pharmaceuticals discloses event of default under credit agreement
PremiumThe Fly
Eagle Pharmaceuticals discloses event of default under credit agreement
4M ago
EGRX
Eagle Pharmaceuticals identified material weaknesses in internal control
PremiumThe Fly
Eagle Pharmaceuticals identified material weaknesses in internal control
4M ago
EGRX
Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City
PremiumPress Releases
Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City
5M ago
EGRX
Eagle Pharmaceuticals trading resumes
PremiumThe Fly
Eagle Pharmaceuticals trading resumes
5M ago
EGRX
Eagle Pharmaceuticals trading halted, volatility trading pause
PremiumThe Fly
Eagle Pharmaceuticals trading halted, volatility trading pause
5M ago
EGRX
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q
PremiumPress Releases
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q
5M ago
EGRX
Eagle Pharmaceuticals Announces Management Change
PremiumPress ReleasesEagle Pharmaceuticals Announces Management Change
5M ago
EGRX
Eagle Pharmaceuticals receives notice of non-compliance from Nasdaq
PremiumThe Fly
Eagle Pharmaceuticals receives notice of non-compliance from Nasdaq
5M ago
EGRX
Eagle Pharmaceuticals CEO Scott Tarriff retires
PremiumThe Fly
Eagle Pharmaceuticals CEO Scott Tarriff retires
5M ago
EGRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >